DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 58 filers reported holding DEXCOM INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,750 | +10.3% | 1,522,000 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $4,306 | +2.6% | 1,522,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $4,195 | -99.9% | 1,522,000 | 0.0% | 0.01% | +50.0% |
Q3 2022 | $3,022,000 | +7.9% | 1,522,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $2,801,000 | -40.9% | 1,522,000 | 0.0% | 0.00% | -20.0% |
Q1 2022 | $4,739,000 | -4.7% | 1,522,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $4,974,000 | +43.0% | 1,522,000 | +45.5% | 0.01% | +25.0% |
Q3 2021 | $3,479,000 | -49.4% | 1,046,000 | -60.5% | 0.00% | -50.0% |
Q2 2021 | $6,882,000 | +17.9% | 2,646,000 | 0.0% | 0.01% | +14.3% |
Q1 2021 | $5,837,000 | -86.4% | 2,646,000 | -85.9% | 0.01% | -87.0% |
Q4 2020 | $42,793,000 | +31.2% | 18,801,000 | +45.7% | 0.05% | +17.4% |
Q3 2020 | $32,625,000 | +1.8% | 12,902,000 | 0.0% | 0.05% | -6.1% |
Q2 2020 | $32,038,000 | -18.2% | 12,902,000 | -42.3% | 0.05% | -31.9% |
Q1 2020 | $39,144,000 | -11.5% | 22,360,000 | -25.0% | 0.07% | +14.3% |
Q4 2019 | $44,217,000 | – | 29,802,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |